Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-04-01 00:00:00 ET · period of report 2025-03-31 · accession 0001510281-25-000176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-04-01 | 2025-03-31 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $12.58 | -48.6K | 3.19M | -2% | -$611.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | S | D | 48,623 | $12.58 | 3,188,405 | I - | — | — |